Vanguard Group
ASMB icon

Vanguard Group’s Assembly Biosciences ASMB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.6M Buy
253,825
+37,842
+18% +$686K ﹤0.01% 3245
2025
Q1
$2.06M Buy
215,983
+15,525
+8% +$148K ﹤0.01% 3482
2024
Q4
$3.16M Hold
200,458
﹤0.01% 3432
2024
Q3
$3.03M Hold
200,458
﹤0.01% 3435
2024
Q2
$2.75M Buy
200,458
+4,090
+2% +$56.1K ﹤0.01% 3464
2024
Q1
$2.61M Sell
196,368
-2,142,720
-92% -$28.5M ﹤0.01% 3509
2023
Q4
$1.92M Buy
2,339,088
+99,092
+4% +$81.3K ﹤0.01% 3621
2023
Q3
$1.98M Sell
2,239,996
-33,766
-1% -$29.9K ﹤0.01% 3579
2023
Q2
$2.61M Hold
2,273,762
﹤0.01% 3574
2023
Q1
$1.91M Buy
2,273,762
+80,800
+4% +$67.9K ﹤0.01% 3692
2022
Q4
$2.85M Sell
2,192,962
-9,830
-0.4% -$12.8K ﹤0.01% 3534
2022
Q3
$3.61M Sell
2,202,792
-52,632
-2% -$86.3K ﹤0.01% 3491
2022
Q2
$4.74M Buy
2,255,424
+627,106
+39% +$1.32M ﹤0.01% 3407
2022
Q1
$3.35M Sell
1,628,318
-576,735
-26% -$1.19M ﹤0.01% 3721
2021
Q4
$5.14M Buy
2,205,053
+301,320
+16% +$702K ﹤0.01% 3594
2021
Q3
$6.63M Buy
1,903,733
+20,089
+1% +$69.9K ﹤0.01% 3488
2021
Q2
$7.31M Sell
1,883,644
-122,737
-6% -$476K ﹤0.01% 3375
2021
Q1
$9.23M Buy
2,006,381
+56,714
+3% +$261K ﹤0.01% 3191
2020
Q4
$11.8M Buy
1,949,667
+365,051
+23% +$2.21M ﹤0.01% 2909
2020
Q3
$26.1M Buy
1,584,616
+823
+0.1% +$13.5K ﹤0.01% 2328
2020
Q2
$36.9M Buy
1,583,793
+97,393
+7% +$2.27M ﹤0.01% 2146
2020
Q1
$22M Buy
1,486,400
+36,809
+3% +$546K ﹤0.01% 2239
2019
Q4
$29.7M Buy
1,449,591
+285,763
+25% +$5.85M ﹤0.01% 2340
2019
Q3
$11.4M Sell
1,163,828
-63,125
-5% -$621K ﹤0.01% 2744
2019
Q2
$16.6M Buy
1,226,953
+146,452
+14% +$1.98M ﹤0.01% 2607
2019
Q1
$21.3M Buy
1,080,501
+241,917
+29% +$4.76M ﹤0.01% 2481
2018
Q4
$19M Sell
838,584
-212,870
-20% -$4.82M ﹤0.01% 2467
2018
Q3
$39.1M Buy
1,051,454
+238,952
+29% +$8.87M ﹤0.01% 2266
2018
Q2
$31.9M Buy
812,502
+20,246
+3% +$794K ﹤0.01% 2356
2018
Q1
$38.9M Buy
792,256
+32,417
+4% +$1.59M ﹤0.01% 2200
2017
Q4
$34.4M Buy
759,839
+98,807
+15% +$4.47M ﹤0.01% 2257
2017
Q3
$23.1M Buy
661,032
+50,116
+8% +$1.75M ﹤0.01% 2425
2017
Q2
$12.6M Buy
610,916
+107,065
+21% +$2.21M ﹤0.01% 2665
2017
Q1
$12.8M Buy
503,851
+50,615
+11% +$1.29M ﹤0.01% 2643
2016
Q4
$5.51M Buy
453,236
+18,862
+4% +$229K ﹤0.01% 3025
2016
Q3
$3.13M Hold
434,374
﹤0.01% 3217
2016
Q2
$2.41M Sell
434,374
-36,760
-8% -$204K ﹤0.01% 3309
2016
Q1
$2.37M Buy
471,134
+32,410
+7% +$163K ﹤0.01% 3313
2015
Q4
$3.3M Buy
438,724
+22,879
+6% +$172K ﹤0.01% 3191
2015
Q3
$3.98M Buy
415,845
+38,104
+10% +$364K ﹤0.01% 3075
2015
Q2
$7.28M Buy
377,741
+63,326
+20% +$1.22M ﹤0.01% 2831
2015
Q1
$4.16M Buy
314,415
+187,806
+148% +$2.49M ﹤0.01% 3083
2014
Q4
$995K Buy
126,609
+13,209
+12% +$104K ﹤0.01% 3532
2014
Q3
$929K Sell
113,400
-354,428
-76% -$2.9M ﹤0.01% 3529
2014
Q2
$613K Buy
467,828
+69,600
+17% +$91.2K ﹤0.01% 3622
2014
Q1
$510K Buy
398,228
+120,173
+43% +$154K ﹤0.01% 3651
2013
Q4
$1.06M Buy
278,055
+81,859
+42% +$313K ﹤0.01% 3393
2013
Q3
$567K Buy
196,196
+29,300
+18% +$84.7K ﹤0.01% 3517
2013
Q2
$401K Buy
+166,896
New +$401K ﹤0.01% 3533